1.
J Rheumatol
; 28(9): 2140-1, 2001 Sep.
Artículo
en Inglés
| MEDLINE
| ID: mdl-11550992
2.
Arq Neuropsiquiatr
; 58(2B): 556-9, 2000 Jun.
Artículo
en Portugués
| MEDLINE
| ID: mdl-10920422
RESUMEN
Interferon-beta (IFN-beta) is administered for treatment of multiple sclerosis (MS). We report on a woman with MS who presented with severe Raynaud's phenomenon, livedo-reticularis and digital necrosis two weeks after beginning therapy with IFN-beta. Symptoms improved after the IFN-beta was discontinued and anticoagulation associated with cyclophosphamide and corticoid were introduced. Raynaud's phenomenon is probably a side effect of IFN-beta therapy for multiple sclerosis.